Private Capital Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Private Capital Group's EBS Position: Q2 2022 in Review
Private Capital Group reduced its Emergent Biosolutions (EBS) stake by 4.5% in Q2 2022, selling an estimated $273 and leaving 171 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.
Private Capital Group first reported a position in EBS in Q4 2017 and has held it in 19 quarters since. The position peaked at $177K in Q3 2020. 231 funds tracked by Wall St. Rank hold EBS as of Q2 2022.
- Private Capital Group held 171 shares of Emergent Biosolutions worth $5K as of Q2 2022.
- Private Capital Group sold 8 Emergent Biosolutions shares in Q2 2022, an estimated $273.
- Emergent Biosolutions made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1248 holding.
- Private Capital Group first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 19 quarters since.
- Private Capital Group's Emergent Biosolutions position peaked at $177K in Q3 2020.
- 231 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.
Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.